Skip to content

Effect of anaesthetic technique on the recurrence of breast cancer after surgery.

To compare the recurrence of breast cancer in patients receiving total intravenous anaesthesia with fascial plane block versus sevoflurane based inhalational anaesthesia with opioid analgesia- A pilot study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/12/038966
Enrollment
180
Registered
2021-12-28
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C509- Malignant neoplasm of breast of unspecified site

Interventions

Intervention1: Total intravenous anaesthesia combined with fascial plane blocks: TIVA with propofol infusion combined with PEC1 and SAM block inj fentanyl 1 mcg/kg intravenous. inj propofol 25-100

Sponsors

nil
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Female patients aged 18 to 80 Years 2) ASA physical status 1-3 3) Primary breast cancer without known extension beyond the breast and axillary nodes (i.e. believed to be Tumor Stage 1-3, Nodes 0-2) 4) Scheduled for modified radical mastectomy 5) Wide local excision (lumpectomy) with node dissection 6) Written informed consent

Exclusion criteria

Exclusion criteria: 1) Previous surgery for breast cancer 2) Inflammatory breast cancer 3) Any contraindication to fascial plane blocks (including coagulopathy, allergic to local anaesthetic) 4) Patients with known allergy to eggs or anaesthetic agents (propofol, paracetamol etc.) 5) Patients who have received neoadjuvant chemotherapy prior to surgery 6) Patient not fit for multimodal postoperative therapy (e.g; low ejection fraction) 7) Pregnant patients

Design outcomes

Primary

MeasureTime frame
1) Recurrence of breast cancer (loco-regional or distant) 2) Recurrence free survival Timepoint: two years

Secondary

MeasureTime frame
1) Postoperative pain (numerical rating scale), total consumption of analgesics and nausea vomiting in first 24 hours after the surgery 2) Chronic post incisional pain at 6 months and 1 year 3) Morbidity and mortality during the two year period. Timepoint: 1) 24 hours 2) 6 months and 1 year 3) 2 years

Countries

India

Contacts

Public ContactDr Sofia Jaswal

Homi Bhabha Cancer Hospital and Research Center, Sangrur and Mullanpur, Punjab

sofiapatial@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026